Reporting based on Korean regulator data counted 1,444 adverse-event reports for Wegovy and 1,261 for Mounjaro from launch through June. Nausea and vomiting were common, while records of gallstones and acute pancreatitis after prescribing were also discussed without establishing that the drugs caused those diagnoses. Prescriptions maintained despite duplication alerts, and prescribing to pregnant patients, highlight the need to review medication history with clinicians. Patients should not independently increase doses for cosmetic weight loss and should discuss symptoms. Sudden vision loss while taking semaglutide requires prompt medical assessment.
Back to Health
Reported obesity-drug adverse events highlight dose and prescription checks
The 2,705 reports and diagnoses after treatment do not directly establish incidence rates or causation.